Your search matched 52 results
In this Coronavirus Special Edition Series, we’ve talked a lot about the clinical implications of the COVID-19 pandemic.
The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.
With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.
In this episode of our Coronavirus Special Edition Series, Syneos Health CEO Alistair Macdonald discusses the unique decisions to be made as a pharmaceutical organization practicing corporate responsibility in the name of public health.
In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.
The Department of Health and Human Services (HHS) has selected the Fors Marsh Group to handle the new $250 million coronavirus campaign.
Over the course of the COVID-19 pandemic, information has varied around whether or not – and how severely – children are affected by the virus.
For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.
One major development is the drop in number of social-media conversations about coronavirus.
With the dramatic impact that COVID 19 has had on work, school, social engagements, and overall life as we know it, one would think that people would be anxious to be vaccinated.
Novo Nordisk’s new diabetes drug seemed all set for launch in early 2020, a time nobody could plan for.
An insightful PMLive article by Yvonne Ash (VP Learning Solutions) focusing on the evolving role of learning and development, and how to prepare for a new digital age in pharma.
COVID-19 has accelerated the rate at which we’re seeing change happening around us.
Is Your Mask Up to the Task? | Blog
Deciding when, where, and what mask to wear has been a large topic of discussion as we re-enter into the “New Normal.”
Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.
To help Syneos Health public relations agencies and clients navigate the media relations landscape during the pandemic, we conducted a survey in which we asked journalists to share insights on their coverage of health, medical and pharma/biotech industry topics.
Understanding the impact that telemedicine has had on HCP behaviors including prescribing in the changing COVID-19 landscape.
Trends Update: Healthcare In the 2020 That No One Saw Coming | Perspectives
Our 10th annual trends report came out just over six months ago— in what may now feel like a distant world.
The way we think about and celebrate summer has dramatically changed since this time last year.
How COVID-19 and 3 other barriers will transform healthcare over the next few years.
COVID-19 treatment regimens are underscoring the threat of antimicrobial resistance, which threatens to kill as many as 20 million people per year by 2050.
You might want to think twice about ignoring that call from a random number.
As the pandemic surged, New York City’s Mt.
Leading Through Uncertainty Amidst the Global Pandemic | Perspectives
Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.
COVID-19: Optimizing Promotions with HCP Preferences | Perspectives
Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.
In this PM360 article, Steve Marino, Managing Director of Digital & Social Strategy at Syneos Health Communications, shares "guidance (that) can help marketers navigate their way as they make decisions about what types of content to post, and what not to post."
Part I of a Syneos Health Series on New Oncology Commercialization Strategies
Demonstrating Value in the Real World | Perspectives
Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.
It's Time for a Digital Reset | Perspectives
What should the evolution of your digital strategy look like through COVID-19 and beyond?
Virtual delivery requires you to rethink your content and approaches.